Cypriot Biotech Company Increases Losses to 3.46 Million Euros
Cypriot biotechnology company iDNA Genomics Public Ltd reported significantly increased losses of 3.46 million euros for 2025. The company approved its audited consolidated financial statements, which show a substantial deterioration in the balance sheet compared to the previous year. The report documents the company's financial challenges in its business operations.